{"doc_id": "si-2023-0238-reg-1", "parent_doc_id": "si-2023-0238", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 238 of 2023", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2023, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2023. \n\n(2) The collective citation “the Medicinal Products (Prescription and \n\nControl of Supply) Regulations 2003 to 2023” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 3) regulation 2023 (2) collective citation medicinal product (prescription control supply) regulation 2003 2023 includes regulation", "start_char": 642, "end_char": 932, "source_path": "downloads\\2023\\2023_0238.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ca92cef3f9411434ac4ead4be1002a1dd0d66868e7043e75dd18b5448356544e", "cross_refs": []}
{"doc_id": "si-2023-0238-reg-2", "parent_doc_id": "si-2023-0238", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 238 of 2023", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2023, "heading": "In these Regulations “Principal Regulations” means the Medicinal", "text_raw": "2. \n\nIn these Regulations “Principal Regulations” means the Medicinal \nProducts (Prescription and Control of Supply) Regulations 2003 (S.I. No. \n540 of 2003).", "text_norm": "2 regulation principal regulation mean medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003)", "start_char": 932, "end_char": 1093, "source_path": "downloads\\2023\\2023_0238.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ca92cef3f9411434ac4ead4be1002a1dd0d66868e7043e75dd18b5448356544e", "cross_refs": []}
{"doc_id": "si-2023-0238-reg-3", "parent_doc_id": "si-2023-0238", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 238 of 2023", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2023, "heading": "3. The Principal Regulations are amended –", "text_raw": "3. The Principal Regulations are amended – \n\n(a) \n\nin Regulation 4(1) (as amended by Regulation 3 of the \nMedicinal Products (Prescription and Control of Supply) \n(Amendment) (No. 4) Regulations 2021 (S.I. No. 81 of 2021)) \nby substituting for the definition of “clinical practice guidelines” \nthe following: \n\n“‘clinical practice guidelines’ or “CPG” means the clinical \npractice guidelines prepared and published by the Pre-Hospital \nEmergency Care Council or in the case of Naloxone only means \nthe clinical practice guidelines prepared and published by the PreHospital Emergency Care Council or \nthe Health Service \nExecutive;”, \n\n(b) \n\nin Regulation 4C (inserted by Regulation 4 of the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) \n(No. 2) Regulations 2015 (S.I. No. 449 of 2015)) by substituting \nfor paragraph (c) the following paragraph: \n\n“(c) \n\nsupplying and administering \n\nthe person \nthe \nmedicinal product has been issued with a certificate \nstating that he or she has satisfactorily completed a \ncourse of training, approved by the Pre-Hospital \nEmergency Care Council or, in the case of Naloxone \nonly, approved by the Pre-Hospital Emergency Care \nCouncil or the Health Service Executive, in the use \nof the specific medicinal product, relating to the \nthe \nadministration of \n\nthe medicinal product, \n\nNotice of the making of this Statutory Instrument was published in \n\"Iris Oifigiúil\" of 19th May, 2023. \n\n \n \n \n \n \n \n\f[238] 3 \n\nmanagement of any immediate adverse reaction that \nmay follow from such administration, the storage \nand safe keeping of the medicinal product and the \nclinical practice guidelines and record-keeping \nrequirements for administration of the medicinal \nproduct,”, \n\nand \n\n(c) \n\nin the Tenth Schedule (as amended by Regulation 6 of the \nMedicinal Products (Prescription and Control of Supply) \n(Amendment) Regulations 2018 (S.I. No. 530 of 2018)) – \n\n(i) \n\nby substituting for the text in column 3 of the entry for \n“Naloxone hydrochloride dihydrate 1mg/ml pre-filled \ninjection” the following: \n\n“Adults and children: For the emergency treatment of respiratory depression \nsecondary to known or suspected narcotic overdose in accordance with Clinical \nPractice Guidelines approved by the Pre-Hospital Emergency Care Council or \nthe Health Service Executive.”, and \n\n(ii) by substituting for the text in column 3 of the entry for \n“Naloxone hydrochloride Nasal administration dihydrate", "text_norm": "3 principal regulation amended - (a) regulation 4(1) (as amended regulation 3 medicinal product (prescription control supply) (amendment) (no 4) regulation 2021 (s.i no 81 2021)) substituting definition clinical practice guideline following clinical practice guideline cpg mean clinical practice guideline prepared published pre-hospital emergency care council case naloxone mean clinical practice guideline prepared published prehospital emergency care council health service executive (b) regulation 4c (inserted regulation 4 medicinal product (prescription control supply) (amendment) (no 2) regulation 2015 (s.i no 449 2015)) substituting paragraph (c) following paragraph (c) supplying administering person medicinal product issued certificate stating satisfactorily completed course training approved pre-hospital emergency care council case naloxone approved pre-hospital emergency care council health service executive use specific medicinal product relating administration medicinal product notice making statutory instrument published iris oifigiuil 19th may 2023 238 3 management immediate adverse reaction may follow administration storage safe keeping medicinal product clinical practice guideline record-keeping requirement administration medicinal product (c) tenth schedule (as amended regulation 6 medicinal product (prescription control supply) (amendment) regulation 2018 (s.i no 530 2018)) - (i) substituting text column 3 entry naloxone hydrochloride dihydrate 1mg ml pre-filled injection following adult child emergency treatment respiratory depression secondary known suspected narcotic overdose accordance clinical practice guideline approved pre-hospital emergency care council health service executive (ii) substituting text column 3 entry naloxone hydrochloride nasal administration dihydrate", "start_char": 1093, "end_char": 3549, "source_path": "downloads\\2023\\2023_0238.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ca92cef3f9411434ac4ead4be1002a1dd0d66868e7043e75dd18b5448356544e", "cross_refs": []}
{"doc_id": "si-2023-0238-reg-1", "parent_doc_id": "si-2023-0238", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 238 of 2023", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2023, "heading": "1.8mg nasal spray” the following:", "text_raw": "1.8mg nasal spray” the following: \n\n“Adults and children: For the emergency treatment \nof respiratory depression secondary to known or \nsuspected narcotic overdose in accordance with \nClinical Practice Guidelines approved by the PreHospital Emergency Care Council or the Health \nService Executive.”. \n\nGIVEN under my Official Seal, \n\n16 May, 2023. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n\f4 [238]", "text_norm": "1.8mg nasal spray following adult child emergency treatment respiratory depression secondary known suspected narcotic overdose accordance clinical practice guideline approved prehospital emergency care council health service executive  given official seal 16 may 2023 stephen donnelly minister health 4 238", "start_char": 3549, "end_char": 3974, "source_path": "downloads\\2023\\2023_0238.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ca92cef3f9411434ac4ead4be1002a1dd0d66868e7043e75dd18b5448356544e", "cross_refs": []}
{"doc_id": "si-2023-0238-explanatory-note", "parent_doc_id": "si-2023-0238", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 238 of 2023", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2023, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to provide for the approval of courses by \nthe Health Service Executive for persons who may supply and administer \nNaloxone in an emergency. \n\nThese Regulations also provide for the Health Service Executive to prepare and \npublish clinical practice guidelines for the supply and administration of \nNaloxone. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 3) Regulations 2023. \n\n \n \n \n \n \n\f[238] 5 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-478) 75. 5/23. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation provide approval course health service executive person may supply administer naloxone emergency regulation also provide health service executive prepare publish clinical practice guideline supply administration naloxone regulation may cited medicinal product (prescription control supply) (amendment) (no 3) regulation 2023 238 5 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-478) 75 5 23 propylon", "start_char": 3974, "end_char": 5179, "source_path": "downloads\\2023\\2023_0238.pdf", "extraction_method": "pdfminer", "checksum": "sha256:ca92cef3f9411434ac4ead4be1002a1dd0d66868e7043e75dd18b5448356544e", "cross_refs": []}
